Literature DB >> 9724313

In vitro release of vascular endothelial growth factor during platelet aggregation.

J P Maloney1, C C Silliman, D R Ambruso, J Wang, R M Tuder, N F Voelkel.   

Abstract

Platelet aggregation is a cardinal feature of both vascular repair and vascular disease. During aggregation platelets release a variety of vasoactive substances; some of these promote angiogenesis, endothelial permeability, and endothelial growth, actions shared by vascular endothelial growth factor (VEGF). This study was undertaken to investigate the hypothesis that VEGF is released by aggregating platelets. We found that VEGF was secreted during the in vitro aggregation of platelet-rich plasma induced by thrombin, collagen, epinephrine, and ADP (range 23-518 pg VEGF/ml). Furthermore, serum VEGF levels were elevated compared with plasma (230 +/- 63 vs. 38 +/- 8 pg VEGF/ml), indicative of VEGF release during whole blood coagulation. Lysates of apheresed, leukocyte-poor platelet units contained significant amounts of VEGF (2.4 +/- 0.8 pg VEGF/mg protein). VEGF message and protein were also present in a megakaryocytic cell line (Dami cell). These results suggest constitutive roles for platelet VEGF in the repair of intimal vessel injury and in the altered permeability and intimal proliferation seen at sites of platelet aggregation and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724313     DOI: 10.1152/ajpheart.1998.275.3.H1054

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  46 in total

1.  Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.

Authors:  L Ma; S N Elliott; G Cirino; A Buret; L J Ignarro; J L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.

Authors:  Li Ma; Rafael Perini; Webb McKnight; Michael Dicay; Andre Klein; Morley D Hollenberg; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

3.  Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin.

Authors:  J Etulain; C Fondevila; S Negrotto; M Schattner
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

Review 5.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

6.  Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist.

Authors:  L Ma; M D Hollenberg; J L Wallace
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.

Authors:  Munechika Enjoji; Makoto Nakamuta; Koji Yamaguchi; Satoshi Ohta; Kazuhiro Kotoh; Marie Fukushima; Masami Kuniyoshi; Tomomi Yamada; Masao Tanaka; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor.

Authors:  Chung-Pin Li; Fa-Yauh Lee; Shinn-Jang Hwang; Rei-Hwa Lu; Wei-Ping Lee; Yee Chao; Sung-Sang Wang; Full-Young Chang; Jacqueline Whang-Peng; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material.

Authors:  Eun-Seok Kim; Jae-Jin Kim; Eun-Jin Park
Journal:  J Adv Prosthodont       Date:  2010-03-31       Impact factor: 1.904

10.  A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury.

Authors:  Alexey Y Kolyada; Hocine Tighiouart; Mary C Perianayagam; Orfeas Liangos; Nicolaos E Madias; Bertrand L Jaber
Journal:  Kidney Int       Date:  2009-03-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.